English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

HIV-1 Infected Russian Children and Adolescents – a 24 Week Study Hedy Teppler, MD; Andrey Shuldyakov, MD; Natalia Gankina, PhD; Valeriy Kulagin, PhD; Firaya Nagimova, PhD; Tatiana Shimonova, PhD; Dmitriy Sonin, PhD; Vladimir Sotnikov, MD; Natalia Zakharova, MD; Brenda Homony, MS; Deng Wang, PhD; Grigoriy Moshkovich, MD; Merck and Co., Inc., Whitehouse Station, NJ; Regional Center for Prevention and Control of AIDS and Infectious Diseases, Saratov, Russia; Regional Center for Prevention and Control of AIDS and Infectious Diseases, Krasnoyarsk, Russia; Clinical Center for Prevention and Control of AIDS and Infectious Diseases, Krasnodar, Russia; Republican Center for Prevention and Control of AIDS and Infectious Diseases, Kazan, Russia; Infectious Clinical Hospital #2 of Moscow City Healthcare Department, Moscow, Russia; Regional Clinical Dermatovenerologic Dispensary, Ryazan, Russia; Regional Center for Prophylaxis and Control of AIDS and Infectious Diseases, Kaluga, Russia; Centre for Prophylaxis and Control of AIDS and Infectious Diseases, St. Petersburg, Russia; Regional Centre for Prevention and Control of AIDS and Infectious Diseases, Nizhniy Novgorod, Russia

1617Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study